Page results
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
Education and training videos for Red Cell Network patients
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
Patient information for Red Cell Network patients
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
File results
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0199 - Patients diagnosed with Cauda Equina Syndrome
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0192 - Non emergency patient transport - NEPTS and taxi procurement
-
FOI/2023/0195 - Patient level costing system and integrated data platform
-
FOI/2023/0208 - Patient trolleys/ stretchers
-
FOI/2023/0214 - Patients waiting over 78 weeks for elective care